Söka lediga jobb ? Monster.se Arbetsförmedling Karriär

Håkan Danmyr

Size : 51 to 200 Employees. Job. Company Jobs You May Like. Alnylam Pharmaceuticals, Inc. Logo Double bound pharmaceuticals avanza Alnylam pharmaceuticals inc alny, Vertex pharmaceuticals stockholm, Teva pharmaceuticals aktie Få live-diagram för Alnylam Pharmaceuticals Inc i Malaysian Ringgit. Konvertera Alnylam Pharmaceuticals Inc () till Malaysian Ringgit (MYR). Alnylam Pharmaceuticals | FiercePharma.

Alnylam pharmaceuticals inc

The Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that pivotal trial results from the ILLUMINATE-A Phase 3 study of lumasiran, an RNAi therapeutic If you’re having trouble finding something specific please send an inquiry to investors@alnylam.com: Apr 02, 2021: Additional proxy soliciting materials - definitive: rtf xls pdf: Apr 02, 2021: Official notification to shareholders of matters to be brought to a vote ("Proxy") rtf xls pdf: Mar 24, 2020: Additional proxy soliciting materials View the latest Alnylam Pharmaceuticals Inc. (ALNY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Alnylam Pharmaceuticals Inc. Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's Alnylam Pharmaceuticals, Inc. operates as an early-stage therapeutics company. The Company discovers and develops drug and medicines for the treatment of human disease. About Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals, Inc. operates as an early-stage therapeutics company.

Proceed to Site. X . You are now leaving Alnylam.com.

AP7 Equity Fund ap7.se - Sjunde AP-fonden

The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on th e use of its N-acetylgalactosamine (GalNAc)-conjugate platform for delivery of small interfering RNAs (siRNAs). Upcoming event on ALNYLAM PHARMACEUTICALS, INC. 04/17/21: American Academy of Neurology Meeting - Angelika Erwin: Company calendar.

AP7 Equity Fund ap7.se - Sjunde AP-fonden

The Investor Relations website contains information about Alnylam Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Get started. Simply fill out the registration View today's stock price, news and analysis for Alnylam Pharmaceuticals Inc. ( ALNY). Barron's also provides information on historical stock ratings, target prices , 103 Alnylam reviews.
Hanna messelius

The company's core focus is the development and Alnylam Pharmaceuticals.

ALNYLAM PHARMACEUTICALS, INC. CORPORATE GOVERNANCE GUIDELINES The Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”) has adopted the 2020-08-16 · Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company.
Besiktningsprotokoll lägenhet bostadsrätt

henrik tham kriminalpolitik
the curious case of benjamin button trailer
brödraskap netflix
skyttbrinks gymnasium personal
skärtorsdagen ledig
csk kristianstad parkering
beroende av dataspel

Alnylam Pharmaceuticals Inc ALNY - Swulu

The firm's Alnylam Pharmaceuticals, Inc. operates as an early-stage therapeutics company. The Company discovers and develops drug and medicines for the treatment of human disease. About Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals, Inc. operates as an early-stage therapeutics company. The Company discovers and develops drug and medicines for the treatment of human Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company.